Brenda M. Maloney Shafer, Partner

Publications and Presentations

Article
Brenda M. Maloney ShaferBrenda M. Maloney Shafer
"To Be or Not to 340B: HHS Issues Advisory Opinion and New GAO Report Sheds Light on HRSA’s Enforcement Pullback"Pratt's Government Contracting Law ReportBy: Brenda M. Maloney Shafer, Richard B. Davis, David M. BlankMany drug manufacturers have decided that the Health Resources and Services Administration’s Office of Pharmacy Affairs guidance on contract pharmacy arrangements is no longer binding. Accordingly, some have curtailed selling 340B-priced drugs based on contract pharmacy encounters, causing a significant... Read More
"The 340B Drug Pricing Program Year in Review: What's Smoke and What's Fire in a Changing Landscape" Quarles & Brady Pharmacy Law Symposium